Sigma-Tau S.p.A: Pharmaceuticals and Healthcare Company Profile & SWOT ReportiCD ResearchFebruary 6, 2012 18 Pages - SKU: ICDR6793530 |
| Synopsis ICD Research's Sigma-Tau S.p.A: Pharmaceuticals and Healthcare Company Profile & SWOT Report contains in depth information and data about the company and its operations. The profile contains a company overview, business description, SWOT analysis, key facts, information on products and services, details of locations and subsidiaries. Summary ICD Research's Sigma-Tau S.p.A: Pharmaceuticals and Healthcare Company Profile & SWOT Report is a crucial resource for industry executives and anyone looking to access key information about Sigma-Tau S.p.A.. ICD Research's Sigma-Tau S.p.A: Pharmaceuticals and Healthcare Company Profile & SWOT Report report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report. Scope
Sigma-Tau S.p.A. (Sigma-Tau) is an Italy based pharmaceutical company. The company's portfolio offers products for therapeutic areas such as: urologic, bone metabolism and osteoporosis, gastroenterology, cardiovascular and metabolic, rheumatologic, neurological, oncological areas, respiratory, and infectious disease. It also carries research in the areas of metabolism, oncology, cardiovascular disease, central and peripheral nervous system, and immunology. The company's major products include Acesistem, Famodil, Lukasm, Actira, Dolme, Dronal, Elontril and Natulan. It operates research centers in Settimo Milanese, Pomezia, and Piana di Monte Verna in Italy; and Gaithersburg, Maryland. Sigma-Tau also has operations in Europe, Africa and North America. The company is headquartered in Rome, Italy. |
Related Markets
Pharmaceuticals Company Reports
- Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q1 2012
- Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics
- Royalty Financing Terms and Agreements in Pharma, Biotech and Diagnostics
- Partnerships, Licensing, Investments and M&A Deals and Trends for March 2012 in Pharmaceuticals
- Contract Research Organizations (CROs) Market to 2018 - Public-Private Partnerships to Strengthen Research Capacities and Advance Clinical Development Programs

